Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2013 (Vol. 33, No. 19)

Interrupting Cell Signaling

  • Protein kinases, enzymes that phosphorylate proteins and other organic molecules, are increasingly important targets for drug discovery. Inhibiting these enzymes can disrupt signal-transduction pathways that play a critical role in a variety of disorders, particularly cancer and inflammatory diseases. At CHI’s recent “Next-Gen Kinase Inhibitors” conference, presenters ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.